Your browser doesn't support javascript.
loading
Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism.
Kappes, Emily C; Kattamuri, Chandramohan; Czepnik, Magdalena; Yarawsky, Alexander E; Brûlé, Emilie; Wang, Ying; Ongaro, Luisina; Herr, Andrew B; Walton, Kelly L; Bernard, Daniel J; Thompson, Thomas B.
Afiliação
  • Kappes EC; Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH, USA.
  • Kattamuri C; Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH, USA.
  • Czepnik M; Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH, USA.
  • Yarawsky AE; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Brûlé E; Departments of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada.
  • Wang Y; Departments of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
  • Ongaro L; Departments of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
  • Herr AB; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Walton KL; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • Bernard DJ; Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Thompson TB; Departments of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada.
Endocrinology ; 164(3)2023 01 09.
Article em En | MEDLINE | ID: mdl-36718082
ABSTRACT
Inhibins are transforming growth factorfamily heterodimers that suppress follicle-stimulating hormone (FSH) secretion by antagonizing activin class ligands. Inhibins share a common ß chain with activin ligands. Follistatin is another activin antagonist, known to bind the common ß chain of both activins and inhibins. In this study, we characterized the antagonist-antagonist complex of inhibin A and follistatin to determine if their interaction impacted activin A antagonism. We isolated the inhibin Afollistatin 288 complex, showing that it forms in a 11 stoichiometric ratio, different from previously reported homodimeric ligandfollistatin complexes, which bind in a 12 ratio. Small angle X-ray scattering coupled with modeling provided a low-resolution structure of inhibin A in complex with follistatin 288. Inhibin binds follistatin via the shared activin ß chain, leaving the α chain free and flexible. The inhibin Afollistatin 288 complex was also shown to bind heparin with lower affinity than follistatin 288 alone or in complex with activin A. Characterizing the inhibin Afollistatin 288 complex in an activin-responsive luciferase assay and by surface plasmon resonance indicated that the inhibitor complex readily dissociated upon binding type II receptor activin receptor type IIb, allowing both antagonists to inhibit activin signaling. Additionally, injection of the complex in ovariectomized female mice did not alter inhibin A suppression of FSH. Taken together, this study shows that while follistatin binds to inhibin A with a substochiometric ratio relative to the activin homodimer, the complex can dissociate readily, allowing both proteins to effectively antagonize activin signaling.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas / Folistatina Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas / Folistatina Idioma: En Ano de publicação: 2023 Tipo de documento: Article